Showing results (191-200 of 358) with videos related to
Sort By:
Pageof 36
Inflammatory Bowel Diseases|March 4, 2015
Determinants of intestinal permeability in healthy first-degree relatives of individuals with Crohn's diseaseDavid Kevans, Williams Turpin, Karen Madsen, et al.Gut|April 29, 2009
Polymorphisms in E-cadherin (CDH1) result in a mis-localised cytoplasmic protein that is associated with Crohn's diseaseA M Muise, T D Walters, W K Glowacka, et al.Inflammatory Bowel Diseases|August 27, 2009
Assessing disease activity in ulcerative colitis: patients or their physicians?Dan Turner, Anne M Griffiths, David Mack, et al.Inflammatory Bowel Diseases|February 2, 2016
Low Fecal Calprotectin Correlates with Histological Remission and Mucosal Healing in Ulcerative Colitis and Colonic Crohn's DiseaseEran Zittan, Orlaith B Kelly, Richard Kirsch, et al.Journal of the American College of Cardiology|June 13, 2001
The effect of correction of mild anemia in severe, resistant congestive heart failure using subcutaneous erythropoietin and intravenous iron: a randomized controlled studyD S Silverberg, D Wexler, D Sheps, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 30, 2020
Persistent Diarrhea in Patients With Crohn's Disease After Mucosal Healing Is Associated With Lower Diversity of the Intestinal Microbiome and Increased DysbiosisKaren Boland, Larbi Bedrani, Williams Turpin, et al.Plos One|October 3, 2013
Characterization of the gut-associated microbiome in inflammatory pouch complications following ileal pouch-anal anastomosisAndrea D Tyler, Natalie Knox, Boyko Kabakchiev, et al.Gut|May 24, 2012
Preoperative biological therapy and short-term outcomes of abdominal surgery in patients with inflammatory bowel diseaseMatti Waterman, Wei Xu, Amreen Dinani, et al.Digestive Diseases and Sciences|May 9, 2018
Stricturing and Fistulizing Crohn's Disease Is Associated with Anti-tumor Necrosis Factor-Induced Psoriasis in Patients with Inflammatory Bowel DiseaseAdam V Weizman, Robyn Sharma, N M Afzal, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 9, 2021
Patients With Low Drug Levels or Antibodies to a Prior Anti-Tumor Necrosis Factor Are More Likely to Develop Antibodies to a Subsequent Anti-Tumor Necrosis FactorNiels Vande Casteele, Maria T Abreu, Sarah Flier, et al.Pageof 36